Amedisys (AMED) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports Second Quarter 2017 Financial Results
July 26, 2017 5:00 PM EDTBATON ROUGE, La., July 26, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2017.
Three Month Periods Ended June 30, 2017 and 2016
Net service revenue increased $18.1Â million to $378.8Â million compared to $360.7Â million in 2016.Net income attributable to Amedisys, Inc. of $4.5Â million compared to $10.7Â million in 2016.Net income attributable to Amedisys, Inc. per diluted share of $0.13 compared to $0.32 in 2016.Adjusted Quarterly Results*
Adjusted EBITDA of $36.1Â million compared to $29.8Â million in 2016.Adjusted net service revenue of $378.8Â million compared to... More


